MONROE, La. (KNOE) - The Louisiana Department of Agriculture and Forestry says they've completed testing on the first batch of medical marijuana produced by Louisiana State University’s (LSU’s) sub-contractor GB Sciences of Louisiana, LLC (LSU-GBSL).
In a news release sent to KNOE, LDAF says:
“We are pleased to announce that LSU-GBSL's final medical marijuana product has passed all testing and is cleared for immediate release to the medical marijuana pharmacies,” Louisiana Agriculture and Forestry Commissioner Mike Strain, D.V.M. said. “We look forward to continuing our working relationship with LSU-GBSL and SU-ADB/ILERA as we move into the next phase of the program. We also want to thank everyone who has worked tirelessly from inception through production and testing to make this a reality.”
Testing was the last hurdle before medical marijuana hit store shelves.
Louisiana allows medical marijuana for these conditions: cancer, positive status for HIV, AIDS, cachexia or wasting syndrome, seizure disorders, epilepsy, spasticity, Crohn’s disease, muscular dystrophy, multiple sclerosis, glaucoma, Parkinson’s disease, severe muscle spasms, intractable pain, post-traumatic disorder, and some symptoms associated with autism spectrum disorder, according to the LDAF's website.
Medical marijuana is expected to be available in a matter of days.